Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
27 results
- D3.147 - The inhaled PDE4 inhibitor tanimilast shows a broad anti-inflammatory effect in two mouse models of asthma induced by house dust mite
- D3.148 - Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab
D3.149 - Worse airflow obstruction but not type 2 biomarkers identifies super-responders to tezepelumab in a real life clinic setting
- D3.150 - Effects of benralizumab on T cell adhesion molecules in severe eosinophilic asthma: modulation by IL-25 and IL-33
- D3.151 - Prevalence and clinical characteristics of adult asthma patients with different phenotype across GINA step 1 to 5 asthma
D3.152 - Phenotype and treatment response of allergic patients with severe asthma: a real-world experience from Argentina
- D3.154 - Safety of allergen immunotherapy in patients with severe asthma. A real-world, multicentre, observational retrospective study
D3.155 - IL-1 signaling pathway molecules as key markers in childhood severe asthma
- D3.156 - Self-reported asthma symptoms and asthma medication usage in patients with possible asthma: A MASK-air® real-world study
D3.157 - A study of the detailed patterns of wheeze presence and absence from infancy through to adolescence
- D3.158 - Clinical and functional profile of children with asthma in a tertiary referral hospital
D3.159 - Investigation of Huai Qi Huang Granules' Impact and Mechanism on Asthmatic Mice's Antiviral Capability
- D3.162 - The Effects of Phthalate Exposure on Asthma via Microbiota Changes
- D3.163 - Mast cell activation test and airway hyperresponsiveness in cat allergy: investigating the link to cat allergen induced asthma
D2.332 - Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results from a Focus Group
D2.325 - Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
D2.326 - Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study
D2.327 - Outcome of hematopoietic stem cells transplantation for inborn error of immunity in Vietnam
D2.328 - Comparison of the frequency of viral infections in immunocompromised patients receiving immunoglobulin by different routes
D2.329 - Impact of Berotralstat on Quality of Life among Patients with Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download